Standard drug tests do not test for psilocybin. The routine panels used for employment screening, federal workplace testing, and Department of Transportation testing do not include psilocybin or its active metabolite, psilocin. You would need to be subjected to a specialized, separately ordered test for it to be detected.
What Standard Drug Tests Actually Screen For
The federal workplace drug testing panel, which sets the baseline for most employer screening in the U.S., covers marijuana, cocaine, opioids (including codeine, morphine, hydrocodone, oxycodone, and fentanyl), amphetamines (including MDMA), and PCP. That’s it. This panel applies to both urine and oral fluid testing formats.
DOT-regulated testing for truck drivers, pilots, and other safety-sensitive workers is even narrower, covering five drug classes: marijuana, cocaine, opiates, amphetamines, and PCP. Psilocybin is not in any of these categories. A standard 10-panel or 12-panel test typically expands coverage to benzodiazepines, barbiturates, or methadone, but still does not add psilocybin.
When Psilocybin Testing Can Happen
Psilocybin detection requires a specialized test that a lab or employer would have to specifically request. These tests use advanced techniques like liquid chromatography-tandem mass spectrometry (LC-MS/MS), which can detect psilocin in urine at concentrations as low as 0.3 nanograms per milliliter. This level of sensitivity exists, but the equipment and analysis are expensive and not part of any routine screening workflow.
Situations where specialized psilocybin testing might be ordered include forensic investigations, clinical poisoning cases, or an employer who has specifically added it to a company-run (non-DOT) testing program. DOT regulations allow employers to run their own additional testing beyond the federal requirements, and in theory an employer could add psilocybin to that custom panel. In practice, very few do.
How Quickly Your Body Clears Psilocybin
Even if you were tested specifically for psilocybin, the detection window is remarkably short. Your body converts psilocybin into psilocin almost immediately after ingestion. In fact, researchers studying the pharmacokinetics of oral psilocybin found no psilocybin at all in plasma or urine, only psilocin. The elimination half-life of psilocin is about 3 hours, meaning your body clears most of it within 12 to 15 hours.
Less than 2% of psilocin is cleared through the kidneys intact. The rest is broken down by the liver and excreted as a metabolite called psilocin glucuronide. Some people show an extended elimination phase where this metabolite slowly converts back to free psilocin, but even so, urine detection is generally limited to roughly 24 hours after use.
Blood and saliva tests are even less useful for detection. Psilocin is metabolized so rapidly that these samples would need to be collected within a few hours of ingestion to return a positive result.
Hair Testing for Psilocybin
Hair follicle tests can theoretically detect psilocin, but the results are unreliable. Multiple research teams have attempted to measure psilocin in hair samples from known users, and the findings are inconsistent. Some studies found no positive results at all. Others detected psilocin only in very small quantities, measured in single-digit picograms per milligram of hair, which is orders of magnitude lower than what hair tests typically detect for other drugs.
One study of a repeated user found psilocin at just 2.5 to 5.4 picograms per milligram across different hair segments. Psilocybin itself was generally undetectable in hair because it degrades quickly. Researchers have described psilocybin as “unstable” in hair samples and have largely focused on psilocin alone, with limited success. Hair testing for psilocybin is not commercially available in any standard panel and remains a research-level technique with significant limitations.
Why Psilocybin Is Rarely Tested For
Several practical factors explain why psilocybin stays off standard panels. The drug clears the body fast, making it hard to catch. The testing equipment required is specialized and costly. And from an employer’s perspective, the federal guidelines that shape most workplace testing programs simply don’t include it. Adding a drug to a testing panel costs money per specimen, and most employers stick to the substances the government mandates.
Psilocybin also doesn’t cross-react with the immunoassay screening methods used in standard urine cups. This means it won’t trigger a false positive for any of the drugs that are on the panel. You won’t test positive for PCP, amphetamines, or anything else because of psilocybin use.